跳至主要内容
临床试验/NCT04320901
NCT04320901Unknown不适用

Comparative Analysis Between Harmonic Versus LigaSure in Transoral Endoscopic Thyroidectomy: A Randomized Controlled Trial

Inha University Hospital2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2020年4月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
40
试验地点
2
主要终点
Blood loss

研究概览

简要总结

Open label randomized controlled study, for Harmonic versus Ligasure in transoral endoscopic thyroid surgery.

详细描述

  • This is a prospective randomized controlled study. The principal investigator or another clinical investigator in charge will individually inform the patients about the study, on the day before surgery.
  • When informed consent is obtained, an investigator in charge of randomization only, will randomize the patients.
  • According to randomization, the experimental group will Ligasure and the control group will use Harmonic ACE 7+. Other than the randomized use of energy devices, the protocol for TOETVA is performed as usual.
  • Operation time (from insertion of the laparoscopic camera to removal of the camera), number of times the camera was cleaned, intraoperative blood loss will recorded.
  • Postoperative hospital stay, visual analog pain scale, blood cell count and inflammatory parameters, postoperative drain amount will recorded.
  • Complications of thyroid surgery (vocal cord dysfunction, hypoparathyroidism) are compared for safety assessment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who planned to transoral endoscopic thyroidectomy
  • Age between 20 to 70
  • Voluntarily consenting to the study and study agreement
  • No local invasion or distant metastasis
  • Normal vocal cord function in laryngoscopic exam
  • No significant abnormalities in preoperative laboratory tests

排除标准

  • Take aspirin or antiplatelet drugs within 7 days before admission
  • Uncontrolled hypertension, diabetes, chronic renal failure, or coagulation disease
  • History of cardiovascular disease (angina pectoris, heart failure, myocardial infarction, history of coronary artery disease, stroke, transient ischemic attack)
  • Substance abuse and alcohol abuse
  • History of esophageal and airway diseases
  • Patient was participated in other clinical trials within 30 days
  • History of neck irradiation or surgery
  • History of severe drug allergies
  • Pregnant or lactating women

结局指标

主要结局

Blood loss

时间窗: During the procedure

Estimated blood loss during the lobectomy

Camera cleaning frequency

时间窗: During the procedure

Numbers of camera cleaning during the lobectomy

Operation time

时间窗: During the procedure

Surgery time during the thyroid lobectomy

次要结局

  • Drain amount(Postoperative 1st and 2nd days)
  • Pain score(Postoperative 1st and 2nd days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jin Wook Yi

Assistant Professor

Inha University Hospital

研究点 (2)

Loading locations...

相似试验